{"id":39104,"date":"2025-05-27T11:59:10","date_gmt":"2025-05-27T11:59:10","guid":{"rendered":"https:\/\/drterziler.com\/kok-hucre\/hematological-treatments\/"},"modified":"2026-04-26T13:13:56","modified_gmt":"2026-04-26T13:13:56","slug":"hematolojik-uygulamalar","status":"publish","type":"page","link":"https:\/\/drterziler.com\/tr\/kok-hucre\/hematolojik-uygulamalar\/","title":{"rendered":"Hematolojik Uygulamalar"},"content":{"rendered":"<div class=\"page-content\">\n<div id=\"header-area\">\n<div class=\"container\" id=\"firstContent\">\n<div class=\"header-content d-flex flex-column\">\n<h1 class=\"content-title h1-header\">Hematolojik Uygulamalar<\/h1>\n<div class=\"content-paragraph\">\n<p class=\"p-text\">Hematolojik hastal\u0131klar, kan ve kan yap\u0131c\u0131 organlar\u0131 etkileyen hastal\u0131klard\u0131r. Bu grupta yer alan hastal\u0131klar aras\u0131nda l\u00f6semi, lenfoma, miyelom, aplastik anemi, orak h\u00fccreli anemi ve talasemi gibi ciddi ve bazen ya\u015fam\u0131 tehdit eden durumlar bulunur. K\u00f6k h\u00fccre tedavisi, \u00f6zellikle hematopoetik (kan yap\u0131c\u0131) k\u00f6k h\u00fccrelerin kullan\u0131m\u0131yla, bu hastal\u0131klar\u0131n tedavisinde devrim niteli\u011finde bir yakla\u015f\u0131m sunar. G\u00fcn\u00fcm\u00fczde baz\u0131 hematolojik hastal\u0131klar\u0131n k\u00fcratif (tam iyile\u015ftirici) tek tedavisi olarak k\u00f6k h\u00fccre nakli kabul edilmektedir.<\/p>\n<\/p><\/div>\n<nav aria-label=\"breadcrumb\" class=\"breadcrumbs\">\n<ul class=\"d-flex align-items-center mb-0\">\n<li><a class=\"link\" href=\"https:\/\/drterziler.com\/tr\/\"><span>Dr. Terziler Exclusive Clinic<\/span><\/a><\/li>\n<li class=\"separator\">\u00bb<\/li>\n<li><a class=\"link\" href=\"https:\/\/drterziler.com\/tr\/sac-tedavileri\/kok-hucre\/\"><span>K\u00f6k H\u00fccre<\/span><\/a><\/li>\n<li class=\"separator\">\u00bb<\/li>\n<li class=\"current-page\"><span>Hematolojik Uygulamalar<\/span><\/li>\n<\/ul>\n<\/nav><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<section id=\"content-area\">\n<div class=\"container my-5\">\n<div class=\"row align-items-start\">\n<div class=\"col-md-6 order-2 order-md-1\">\n<div class=\"custom-toc-box\">\n<div id=\"toc-header\">\n<h4>\u0130\u00e7indekiler<\/h4>\n<div class=\"toc-toggle-icon\"><\/div>\n<\/p><\/div>\n<div class=\"toc-full-divider\"><\/div>\n<div id=\"toc-body\">\n<div id=\"toc-container\"><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"col-md-6 order-1 order-md-2\" id=\"jForm\">\n                <script type=\"text\/javascript\" src=\"https:\/\/form.jotform.com\/jsform\/242882264736970\"><\/script>\n            <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"container\">\n<div class=\"img-thumb\">\n            <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/drterziler.com\/wp-content\/uploads\/2025\/05\/Hematolojik-Uygulamalar.webp\" sizes=\"auto, (max-width: 1140px) 100vw, 1140px\" srcset=\"https:\/\/drterziler.com\/wp-content\/uploads\/2025\/05\/Hematolojik-Uygulamalar.webp 1140w, https:\/\/drterziler.com\/wp-content\/uploads\/2025\/05\/Hematolojik-Uygulamalar-300x168.webp 300w, https:\/\/drterziler.com\/wp-content\/uploads\/2025\/05\/Hematolojik-Uygulamalar-1024x575.webp 1024w, https:\/\/drterziler.com\/wp-content\/uploads\/2025\/05\/Hematolojik-Uygulamalar-768x431.webp 768w\" alt=\"\" width=\"1140\" height=\"640\">\n        <\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">Hematopoetik K\u00f6k H\u00fccre Nedir?<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">Hematopoetik k\u00f6k h\u00fccreler (HKH), t\u00fcm kan h\u00fccrelerine (eritrosit, l\u00f6kosit, trombosit) d\u00f6n\u00fc\u015febilen ve genellikle kemik ili\u011fi, periferik kan veya kordon kan\u0131 gibi kaynaklardan elde edilen \u00f6zel h\u00fccrelerdir. Bu h\u00fccreler, bozulmu\u015f ya da yok olmu\u015f kan h\u00fccrelerinin yeniden \u00fcretilmesini sa\u011flar ve ba\u011f\u0131\u015f\u0131kl\u0131k sistemini yeniden yap\u0131land\u0131rabilir.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">K\u00f6k H\u00fccre Nakli T\u00fcrleri<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">Otokolog (Ki\u015finin Kendisinden) Nakil: Kendi k\u00f6k h\u00fccreleri \u00f6nceden toplan\u0131r, y\u00fcksek doz kemoterapi sonras\u0131 tekrar v\u00fccuda verilir. \u00d6zellikle lenfoma ve multipl miyelom gibi hastal\u0131klarda yayg\u0131n olarak kullan\u0131l\u0131r. Allojenik (Vericiden) Nakil: Genetik olarak uyumlu bir vericiden al\u0131nan k\u00f6k h\u00fccreler kullan\u0131l\u0131r. Akut ve kronik l\u00f6semiler, aplastik anemi, talasemi, orak h\u00fccre anemisi gibi bir\u00e7ok hastal\u0131kta tercih edilir. Avantaj\u0131, hastal\u0131kl\u0131 ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin tamamen de\u011fi\u015ftirilmesidir. Kordon Kan\u0131 Nakli: Do\u011fum s\u0131ras\u0131nda toplanan kordon kan\u0131ndan elde edilen k\u00f6k h\u00fccrelerdir. \u00d6zellikle \u00e7ocuk hastalarda kullan\u0131l\u0131r, doku uyumu gereksinimi daha esnektir.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">Ba\u015fl\u0131ca Tedavi Edilen Hematolojik Hastal\u0131klar<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">L\u00f6semi (Kan Kanseri): L\u00f6semi, beyaz kan h\u00fccrelerinin kontrols\u00fcz \u00e7o\u011falmas\u0131yla olu\u015fan bir kanser t\u00fcr\u00fcd\u00fcr. Allojenik k\u00f6k h\u00fccre nakli, kemoterapiyle yok edilen l\u00f6semik h\u00fccrelerin yerine sa\u011fl\u0131kl\u0131 k\u00f6k h\u00fccrelerin yerle\u015ftirilmesiyle hastal\u0131\u011f\u0131n tamamen iyile\u015fmesini sa\u011flayabilir. Akut miyeloid l\u00f6semi (AML) ve akut lenfoblastik l\u00f6semi (ALL) gibi agresif t\u00fcrlerde s\u0131kl\u0131kla kullan\u0131l\u0131r. Lenfoma: Lenfatik sistemin kanseri olan lenfomada, \u00f6zellikle Hodgkin ve non-Hodgkin lenfoma t\u00fcrlerinde otolog k\u00f6k h\u00fccre nakli, y\u00fcksek doz tedavi sonras\u0131 iyile\u015fme sa\u011flamak i\u00e7in tercih edilmektedir. Hastal\u0131\u011f\u0131n n\u00fcks etti\u011fi durumlarda etkin bir tedavi se\u00e7ene\u011fidir. Multipl Miyelom: Plazma h\u00fccrelerinin kontrols\u00fcz \u00e7o\u011falmas\u0131yla olu\u015fan bu kemik ili\u011fi kanserinde, otolog k\u00f6k h\u00fccre nakli standart tedavi protokol\u00fcn\u00fcn bir par\u00e7as\u0131d\u0131r. Y\u00fcksek doz kemoterapi sonras\u0131 k\u00f6k h\u00fccre inf\u00fczyonu ile remisyon s\u00fcresi uzat\u0131labilir. Aplastik Anemi: Kemik ili\u011finin kan \u00fcretim yetisinin tamamen durdu\u011fu bu hastal\u0131kta, allojenik k\u00f6k h\u00fccre nakli hayati \u00f6neme sahiptir. Gen\u00e7 hastalarda ve uygun verici bulundu\u011funda iyile\u015ftirici etkisi y\u00fcksektir. Talasemi ve Orak H\u00fccreli Anemi: Bu kal\u0131tsal kan hastal\u0131klar\u0131nda, k\u00f6k h\u00fccre nakli kal\u0131c\u0131 bir tedavi sunabilir. \u00d6zellikle \u00e7ocuk ya\u015fta yap\u0131lan nakillerde ba\u015far\u0131 oranlar\u0131 y\u00fcksektir. Yeni geli\u015ftirilen gen d\u00fczenleme teknikleriyle birlikte k\u00f6k h\u00fccre tedavileri bu alanda daha da etkili hale gelmektedir.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">K\u00f6k H\u00fccre Nakli S\u00fcreci<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">Haz\u0131rl\u0131k (Kondisyonlama): Y\u00fcksek doz kemoterapi ve\/veya radyoterapi ile mevcut kemik ili\u011fi temizlenir. Nakil (Transplantasyon): K\u00f6k h\u00fccreler damar yoluyla hastaya verilir. \u0130yile\u015fme ve G\u00f6zlem: Yeni k\u00f6k h\u00fccreler kemik ili\u011fine yerle\u015fir ve kan h\u00fccrelerini \u00fcretmeye ba\u015flar. Bu s\u00fcre\u00e7te enfeksiyon riskine kar\u015f\u0131 \u00f6zel \u00f6nlemler al\u0131n\u0131r.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">Olas\u0131 Riskler ve Takip<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">Graft-versus-host hastal\u0131\u011f\u0131 (GVHH): Allojenik nakillerde ba\u011f\u0131\u015f\u0131kl\u0131k h\u00fccrelerinin hastaya sald\u0131rmas\u0131. Enfeksiyonlar: Ge\u00e7ici ba\u011f\u0131\u015f\u0131kl\u0131k zay\u0131fl\u0131\u011f\u0131 nedeniyle s\u0131k g\u00f6r\u00fcl\u00fcr. Organ toksisiteleri: Y\u00fcksek doz tedaviye ba\u011fl\u0131 olarak geli\u015febilir. Bu nedenle tedavi \u00f6ncesi detayl\u0131 de\u011ferlendirme ve sonras\u0131 uzun d\u00f6nem izlem kritik \u00f6neme sahiptir.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<div>\n<div>\n<h2 class=\"h2-header\">Sonu\u00e7<\/h2>\n<\/p><\/div>\n<div>\n<p class=\"p-text\">K\u00f6k h\u00fccre tedavileri, hematolojik hastal\u0131klar\u0131n tedavisinde uzun y\u0131llard\u0131r ba\u015far\u0131yla uygulanmakta olan, bilimsel olarak kan\u0131tlanm\u0131\u015f y\u00f6ntemlerdir. \u00d6zellikle l\u00f6semi, lenfoma ve anemi t\u00fcrlerinde ya\u015fam kurtar\u0131c\u0131 etkiye sahiptir. Geli\u015fen teknoloji ve h\u00fccre m\u00fchendisli\u011fi sayesinde, gelecekte daha g\u00fcvenli, etkili ve ki\u015fiselle\u015ftirilmi\u015f tedavi yakla\u015f\u0131mlar\u0131n\u0131n geli\u015ftirilmesi beklenmektedir.<\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Hematolojik Uygulamalar Hematolojik hastal\u0131klar, kan ve kan yap\u0131c\u0131 organlar\u0131 etkileyen hastal\u0131klard\u0131r. Bu grupta yer alan hastal\u0131klar aras\u0131nda l\u00f6semi, lenfoma, miyelom, aplastik anemi, orak h\u00fccreli anemi ve talasemi gibi ciddi ve bazen ya\u015fam\u0131 tehdit eden durumlar bulunur. K\u00f6k h\u00fccre tedavisi, \u00f6zellikle hematopoetik (kan yap\u0131c\u0131) k\u00f6k h\u00fccrelerin kullan\u0131m\u0131yla, bu hastal\u0131klar\u0131n tedavisinde devrim niteli\u011finde bir yakla\u015f\u0131m sunar. G\u00fcn\u00fcm\u00fczde [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":39045,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-39104","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/pages\/39104","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/comments?post=39104"}],"version-history":[{"count":12,"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/pages\/39104\/revisions"}],"predecessor-version":[{"id":62453,"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/pages\/39104\/revisions\/62453"}],"up":[{"embeddable":true,"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/pages\/39045"}],"wp:attachment":[{"href":"https:\/\/drterziler.com\/tr\/wp-json\/wp\/v2\/media?parent=39104"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}